Q2 2022 Holdings
Filed 2022-08-11 | 137 holdings | $429.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $151.6M | 400,000 | 35.3% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $105.2M | 650,000 | 24.5% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $87.5M | 600,000 | 20.4% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $50.1M | 1,275,000 | 11.7% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $10.1M | 1,000,000 | 2.3% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $4.1M | 1,646,517 | 0.9% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $4.0M | 500,000 | 0.9% |
| Adagio Therapeutics Inc(IVVD) | COM | 00534A102 | $3.3M | 1,000,000 | 0.8% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $3.2M | 250,000 | 0.7% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $2.3M | 250,000 | 0.5% |
| Adagene Inc(ADAG) | ADS | 005329107 | $2.1M | 1,000,000 | 0.5% |
| Cardiff Oncology Inc(CRDF) | COM | 14147L108 | $1.7M | 750,000 | 0.4% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $1.4M | 75,000 | 0.3% |
| Caribou Biosciences Inc(CRBU) | COM | 142038108 | $572.0K | 105,347 | 0.1% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $495.0K | 500,000 | 0.1% |
| Cleveland-Cliffs Inc New(CLF) | COM | 185899101 | $384.0K | 25,000 | 0.1% |
| Lexicon Pharmaceuticals Inc(LXRX) | COM NEW | 528872302 | $132.4K | 71,178,364 | 0.0% |
| WW Intl Inc(WW6) | COM | 98262P101 | $94.7K | 14,818,300 | 0.0% |
| Seagen Inc(SGENUSD) | COM | 81181C104 | $92.9K | 525,000 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $73.8K | 1,100,000 | 0.0% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $64.7K | 7,000,000 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $64.4K | 2,600,000 | 0.0% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $48.0K | 8,750,034 | 0.0% |
| Citigroup Inc(C)Call | COM NEW | 172967424 | $46.0K | 1,000,000 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $43.0K | 4,000,000 | 0.0% |
| Seer Inc(SEER) | COM CL A | 81578P106 | $42.5K | 4,750,000 | 0.0% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $39.7K | 1,500,000 | 0.0% |
| IGM Biosciences Inc(1K0) | COM | 449585108 | $36.1K | 2,000,000 | 0.0% |
| Morphic Hldg Inc | COM | 61775R105 | $35.8K | 1,650,000 | 0.0% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $32.8K | 500,000 | 0.0% |
| Direxion SHS ETF TR(LABUUSD)Call | SP BIOTCH BL NEW | 25490K323 | $27.0K | 4,000,000 | 0.0% |
| Foghorn Therapeutics Inc(FHTX) | COM | 344174107 | $23.4K | 1,720,720 | 0.0% |
| Springworks Therapeutics Inc | COM | 85205L107 | $22.2K | 900,000 | 0.0% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $19.7K | 2,358,968 | 0.0% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $19.7K | 1,000,000 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $19.2K | 1,050,000 | 0.0% |
| Eqrx Inc | COM | 26886C107 | $18.8K | 4,000,000 | 0.0% |
| Schrodinger Inc(SDGR) | COM | 80810D103 | $18.5K | 700,000 | 0.0% |
| Generation BIO Co(GBIOGBX) | COM | 37148K100 | $18.5K | 2,814,191 | 0.0% |
| Erasca Inc(ERAS) | COM | 29479A108 | $17.7K | 3,172,221 | 0.0% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $17.7K | 600,000 | 0.0% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $15.7K | 900,000 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $14.5K | 450,000 | 0.0% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $14.2K | 275,000 | 0.0% |
| Evotec AG(EVO) | SPONSORED ADS | 30050E105 | $13.8K | 1,149,425 | 0.0% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $11.7K | 700,000 | 0.0% |
| Mersana Therapeutics Inc | COM | 59045L106 | $10.2K | 2,200,000 | 0.0% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $9.8K | 700,000 | 0.0% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $9.8K | 3,000,000 | 0.0% |
| I MAB(NBP) | SPONSORED ADS | 44975P103 | $9.6K | 850,000 | 0.0% |